John C. Cheneval
Corporate Officer/Principal presso CASTLE BIOSCIENCES, INC.
Profilo
John C.
Cheneval is currently working as the Executive Director-Business Development at Castle Biosciences, Inc. Prior to his current position, he worked as the Vice President-Pharma Partnerships at HTG Molecular Diagnostics, Inc. from 2018 to 2021.
He also served as the Executive Vice President-Sales & Marketing at Akers Biosciences, Inc. In terms of education, Mr. Cheneval completed his undergraduate degree at LSU Medical School and Louisiana State University.
Posizioni attive di John C. Cheneval
| Società | Posizione | Inizio |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/01/2021 |
Precedenti posizioni note di John C. Cheneval
| Società | Posizione | Fine |
|---|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
| MYMD PHARMACEUTICALS, INC. | Vendite & Marketing | - |
Formazione di John C. Cheneval
| Louisiana State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CASTLE BIOSCIENCES, INC. | Health Technology |
| HTG MOLECULAR DIAGNOSTICS, INC. | Commercial Services |
| Aziende private | 1 |
|---|---|
Akers Biosciences, Inc.
 Akers Biosciences, Inc. Medical SpecialtiesHealth Technology Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- John C. Cheneval
